| Naslov: | Tumor-infiltrating lymphocytes in breast and female genital tract cancers : overlooked potential and unexplored frontiers |
|---|
| Avtorji: | ID Skok, Kristijan (Avtor)
ID Maccio, Umberto (Avtor)
ID Martin, Spencer D. (Avtor)
ID Bräutigam, Konstantin (Avtor) |
|---|
| Datoteke: |  RAZ_Skok_Kristijan_2025.pdf (1,28 MB)
MD5: 8DCD91B4D0143849B3A6BBD2465E886D
 https://doi.org/10.1002/cam4.71023
https://onlinelibrary.wiley.com/doi/10.1002/cam4.71023
|
|---|
| Jezik: | Angleški jezik |
|---|
| Vrsta gradiva: | Znanstveno delo |
|---|
| Tipologija: | 1.02 - Pregledni znanstveni članek |
|---|
| Organizacija: | MF - Medicinska fakulteta
|
|---|
| Opis: | Background: The growing success of cancer immunotherapies has led to significant advances in oncology. However, despite these promising developments, cancer-related mortality remains high for common cancer types such as breast and lower female genital tract cancers. Method: Here, we synthesize recent findings on the prognostic relevance of tumor-infiltrating lymphocytes (TILs) in breast, endometrial, tubo-ovarian, and vulvar cancer. Our analysis covers the relationship between TIL counts and density, immune cell subtype combinations, immunotherapy approaches, and patient outcomes. Results: High TIL infiltration, especially CD8+ T-cells, generally correlates with improved outcomes such as in endometrial cancer (especially the POLE-ultramutated subgroup), invasive breast cancer, and ovarian epithelial tumors. However, in ductal carcinoma in situ (DCIS) of the breast, elevated TIL counts are linked to a worse prognosis. Ethnicity, the tumor microenvironment (TME), and molecular profiles further complicate the prognostic utility of TILs. Conclusions: TIL-based therapies have shown potential in personalized immunotherapy, particularly in recurrent, refractory ovarian cancer. Limited research on rarer gynecologic tumors hinders broader clinical applications. |
|---|
| Ključne besede: | breast cancer, endometrial cancer, fallopian tube, immunotherapy, ovarian cancer, review, tumor microenvironment (TME), tumor‐infiltrating lymphocytes (TILs), vulvar cancer |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Poslano v recenzijo: | 23.06.2025 |
|---|
| Datum sprejetja članka: | 06.03.2025 |
|---|
| Datum objave: | 24.06.2025 |
|---|
| Založnik: | John Wiley & Sons Ltd. |
|---|
| Leto izida: | 2025 |
|---|
| Št. strani: | Str. 1-15 |
|---|
| Številčenje: | Letn. 14, Št. 13, št. članka e71023 |
|---|
| PID: | 20.500.12556/DKUM-94340  |
|---|
| UDK: | 616-006 |
|---|
| COBISS.SI-ID: | 245427715 |
|---|
| DOI: | 10.1002/cam4.71023 |
|---|
| ISSN pri članku: | 2045-7634 |
|---|
| Datum objave v DKUM: | 18.08.2025 |
|---|
| Število ogledov: | 188 |
|---|
| Število prenosov: | 14 |
|---|
| Metapodatki: |    |
|---|
| Področja: | Ostalo
|
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Skupna ocena: | (0 glasov) |
|---|
| Vaša ocena: | Ocenjevanje je dovoljeno samo prijavljenim uporabnikom. |
|---|
| Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
